Healome

Healome Therapeutics

The company develops eye-drop matrix technology to improve drug delivery and treatment for patients with ocular surface diseases.

GelMEDIX

GelMEDIX develops injectable hydrogel scaffolds and regenerative cell therapies to treat degenerative ocular diseases such as geographic atrophy for patients with vision loss.

INEYE Therapeutics

This company develops ocular drug delivery inserts to treat chronic eye conditions such as dry eye and glaucoma for patients.

Eyexora

This company develops therapeutics and medical devices for ophthalmic diseases to treat patients with vision-threatening conditions.

Perfuse Therapeutics

The company develops sustained-release intravitreal therapies to treat ischemia-driven ocular diseases for patients with conditions like glaucoma and diabetic retinopathy.

StemSight

This company develops stem cell therapies using biomaterials to treat corneal blindness in patients with limbal stem cell deficiency and other eye conditions.

Kedalion Therapeutics

This company develops electromechanical ocular delivery devices for patients with eye conditions requiring precise topical medication administration.

EyeYon

This company develops synthetic corneal implants and therapeutic contact lenses for patients with corneal diseases, providing alternatives to traditional donor tissue transplants.